α(v)β3 integrin binding affinity and specificity of SM256 in various species

Journal of Cardiovascular Pharmacology

Volumn 33, Issue 4, 1999, Pages 641-646

  Mousa, Shaker A ^a   Lorelli, William ^a   Mohamed, Seema ^a   Batt, Douglas G ^a   Jadhav, Prabhakar K ^a   Reilly, Thomas M ^a  

^a DUPONT COMPANY   (United States)

Author keywords

(v) 3, (11b) 3, (v) 5, 5 1, and 4 1 integrin ; Arg GlyAsp; Platelet rich plasma

Indexed keywords

3 [[[1 [3 (1H IMIDAZOL 2 YLAMINO)PROPYL] 1H INDAZOL 5 YL]CARBONYL]AMINO] N (MESITYLSULFONYL)ALANINE; FIBRINOGEN; INTEGRIN; INTEGRIN RECEPTOR; UNCLASSIFIED DRUG; VITRONECTIN; INDAZOLE DERIVATIVE; SULFONAMIDE; VITRONECTIN RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL ADHESION; DOG; DRUG INHIBITION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RABBIT; RECEPTOR AFFINITY; RECEPTOR BINDING; SPECIES DIFFERENCE; SWINE; ANIMAL; BINDING COMPETITION; BIOTINYLATION; DRUG ANTAGONISM; METABOLISM; MOUSE;

ANIMALS; BINDING, COMPETITIVE; BIOTINYLATION; DOGS; HUMANS; INDAZOLES; INTEGRINS; MICE; RABBITS; RECEPTORS, VITRONECTIN; SULFONAMIDES; SWINE; VITRONECTIN;

EID: 0032589224     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199904000-00018     Document Type: Article

References (28)

1. Ruoslahti E, Pierschbacher M. Arg-Gly-Asp: a versatile cell recognition sequence. Cell 1986;44:517-8.
2. Hynes RO. Integrins: versatility, modulation and signaling in cell adhesion. Cell 1992;69:11-25.
3. Cheresh D. Integrins: structure, function and biological properties. Adv Mol Cell Biol 1993;6:225-52.
4. Guadagno TM, Ohtsubo M, Roberts JM, et al. A link between cyclin a expression and adhesion dependent cell cycle proliferation. Science 1993;262:1592-75.
5. 1 expression negatively regulates cell growth: reversal by attachment to fibronectin. Mol Biol Cell 1995;6:725-40.
6. Dike LE, Farmer SR. Cell adhesion induces expression of growthassociated genes in suspension arrested fibroblasts. Proc Natl Acad Sci U S A 1988;85:6792-6.
7. Juliano RL, Haskill S. Signal transduction from the extracellular matrix. J Cell Biol 1993;120:577-85.
8. Kornberg LJ, Earp HS, Turner CE, et al. Signal transduction by integrins: increased protein tyrosine phosphorylation caused by clustering of P1 integrins. Proc Natl Acad Sci U S A 1991;88:8392-5.
9. Kornberg L, Earp HS, Parsons JT, et al. Cell adhesion or integrin clustering increased phosphorylation of a focal adhesion associated kinase. J Biol Chem 1992;117:1101-7.
10. Guan JL, Shalloway D. Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation. Nature 1992;358:690-2.
11. Schwartz MA, Cragoe EJ, Lechene CP. pH regulation in spread and round cells. J Biol Chem 1990;265:1327-32.
12. 1, independent of cell shape. Proc Natl Acad Sci U S A 1991;88:7849-53.
13. + antiporter by platelet-derived growth factor. Proc Natl Acad Sci U S A 1992;89:6138-11.
14. 3: induction of calcium oscillations required for protein-tyrosine phosphorylation and ligand-induced spreading of stably transfected cells. Mol Biol Cell 1992;3:989-98.
15. Schwartz MA. Spreading of human endothelial cells on fibronectin or vitronectin triggers elevation of intracellular free calcium. J Cell Biol 1992;120:1003-10.
16. 3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J Cell Biol 1993;121:163-70.
17. McNamee HP, Ingber DE, Schwartz M. Adhesion to fibronectin stimulates inositol lipid synthesis and enhances PDGF-induced inositol lipid breakdown. J Cell Biol 1993;121:673-8.
18. 3 for angiogenesis. Science 1994;264:569-71.
19. 3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest 1995;96:1815-22.
20. 3 inhibit retinal neovascularization in a murine model. Lab Invest 1996;75:563-73.
21. 3 integrin blockade limits neointima hyperplasia and lumen stenosis in stented porcine coronary artery injury in pig. Cardiovasc Res 1997;36:408-28.
22. Mousa S. Recent advances in cell adhesion molecules (CAM) research and development: targeting CAM for therapeutic and diagnostic applications. Drugs Future 1996;21:283-9.
23. Topol EJ, Califf RM, Weisman HF, et al. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. Lancet 1994;343:881-6.
24. Mousa S, Forsythe M, Lorelli W, et al. Discovery of novel nonpeptide antiplatelet GPIIb/IIIa receptor antagonist, DMP754: receptor binding affinity and specificity. Coron Artery Dis 1996;7:767-74.
25. 1 integrins. J Biol Chem 1994;269:20233-8.
26. 1 integrin from a phage display library. J Biol Chem 1993;268:20205-10.
27. 1 integrin from a phage display library. J Cell Biol 1994;124:373-80.
28. 3 selected from random phage display libraries. Biochemistry 1995;34:3948-55.